Maha Dawood

SUNY Upstate Medical University — United States

Medicine · Health Sciences

5h-index1.1kcitations8works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Systemic Lupus Erythematosus Research(5), T-cell and B-cell Immunology(2), PI3K/AKT/mTOR signaling in cancer(2), Monoclonal and Polyclonal Antibodies Research(2), Chronic Lymphocytic Leukemia Research(2)

Publications8 total

1203 Blockade of the mechanistic target of rapamycin elicits rapid and lasting improvement of disease activity through restraining pro-inflammatory T cell lineage specification in patients with active SLE
2022· 1 citedOpen Access
BD-02 Blockade of the mechanistic target of rapamycin elicits rapid and lasting improvement of disease activity through restraining pro-inflammatory T cell lineage specification in patients with active SLE
2018Open Access
Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: a single-arm, open-label, phase 1/2 trial
The Lancet·2018· 390 cited
mTOR activation triggers proinflammatory expansion of IL-4-producing and necrosis-prone double-negative T cells, precedes flares, and serves as target for treatment in patients with systemic lupus erythematosus
Arthritis Research & Therapy·2014· 1 citedOpen Access
Mechanistic Target of Rapamycin Activation Triggers IL-4 Production and Necrotic Death of Double-Negative T Cells in Patients with Systemic Lupus Erythematosus
The Journal of Immunology·2013· 152 citedOpen Access
Brief Report: Attention Deficit and Hyperactivity Disorder Scores Are Elevated and Respond to <i>N</i>‐Acetylcysteine Treatment in Patients With Systemic Lupus Erythematosus
Arthritis & Rheumatism·2013· 97 citedOpen Access
<i>N</i> ‐acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: A randomized, double‐blind, placebo‐controlled trial
Arthritis & Rheumatism·2012· 400 cited
95143045 Quality of life during sequential hormone replacement therapy—A placebo-controlled study
Maturitas·1995· 36 cited

Frequent Co-authors

Zhi‐Wei Lai(7), Lisa Francis(7), Stephen V. Faraone(7), András Perl(7), Hajra Tily(6), Ricardo Garcı́a(6), Paul E. M. Phillips(6), Ashwini Shadakshari(5), Ádám Bartos(3), Jianghong Yu(3), Thomas Winans(3), Ivan Marchena(3), Julie Yu(3), Ryan L. Kelly(2), Rebecca Borsuk(2), Robert Hanczko(1), Eduardo Bonilla(1), Tiffany Caza(1), Brandon Clair(1), Gabriella Miklóssy(1)